1. Altafini R., Scherzer M., Hubatsch D.A., Frezzotti P. (2015). Brinzolamide 1%/ timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study. Journal of Clinical Ophthalmology, 2263-2270

2. Burr J., Azuara-Blanco A., Avenell A., Tuulonen A. (2012). Medical versus surgical interventions for open angle glaucoma. Cochrane Database of Systematic Reviews.

3. Donegan R.K., Lieberman R.L. (2016). Discovery of molecular therapeutics for glaucoma: Challenges, successes, and promising directions. Journal of Medicinal Chemistry, 788-809.

4. Erik R. Swenson. (2014). Safety of carbonic anhydrase inhibitors. Journal of Expert Opinion on Drug Safety, 1-14.

5. Evangelho K., Mogilevskaya M., Losada-Barragan M., Vargas-Sanchez J.K. (2019). Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature. International Ophthalmology, 259-271.

6. Frost S.C., McKenna R. (2014). Carbonic anhydrases: mechanism, regulation, links to disease, and industrial applications. Heidelberg: Springer.

7. Jed Asher Lusthaus and Ivan Goldberg. (2017). Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Journal of Expert Opinion on Drug Safety, 1071-1078

8. Serle J.B., Katz L.J., McLaurin E., Heah T., Ramirez-Davis N., Usner D.W., et al. (2017). Two Phase 3 clinical trials comparing the safety and efficacy of netarsudil to timolol in patients with elevated intraocular pressure. American Journal of Ophthalmology. [Medline].

9. Shoji T. (2016). Correlation between Lamina Cribrosa Tilt, Myopia and Glaucoma Using Optical Coherence Tomography with a Wide Band Femtosecond Mode- 26 locked Laser. Nippon Ganka Gakkai Zasshi, 764-771.

10.Silver L.H. (1998). Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open–angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study. American Journal of Ophthalmology, 400–408.

11. Fabrikantov O.L., Shutova S.V., Sukhorukova A.V. (2015). Sravnitelnaya kharakteristika metodov standartnoy kompyuternoy i konturnoy perimetrii v diagnostike nachalnoy glaukomi [Comparative characteristic of the methods of standard computer and contour perimetry in diagnostics of initial glaucoma]. Oftalmokhirurgiya, 24.

12.Astakhov S.Yu., Tkachenko N.V. (2016). Taflotan® ― Perviy analog prostaglandina-F2α bez konservanta: preimushestva v lechanii bolnih pervichnoy otkritougolnoy glaukomoy [The first analogue of prostaglandin-F2α without preservative: advantages in the treatment of patients with primary open-angle glaucoma]. Oftalmologicheskiye vedomosti, 59-68.

13.Yegorov, Ye.A. (2015). Fiksirovannaya kombinatsiya latanoprosta i timolola v ryadu kombinirovannih preparatov dlya lecheniya glaukomi [Fixed combination of latanoprost and thymol in a series of combined medicines for glaucoma treatment]. Klinicheskaya oftalmologiya, 73-77.

14.Sidikov Z.U. (2013). Invalidnost po prichine zabolevaniy glaza v Uzbekistane [Disability due to eye diseases in Uzbekistan]. Tashkent: Sbornik nauchnih trudov, 6-7.

15.Avetisov S.E., Ye.A. Yegorov, L.K. Moshetova, V.V. Neroyev, H.P. Takhchidi. (2019). Oftalmologiya. Natsionalnoye rukovodstvo [Ophthalmology. National manual]. (2 nd ed.), revised and supplemented. GEOTAR-Media, 685-755.